Gene: MFSD14B
Official Full Name: major facilitator superfamily domain containing 14Bprovided by HGNC
Gene Summary: Predicted to enable transmembrane transporter activity. Predicted to be involved in transmembrane transport. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24753 | MFSD14B Knockout cell line (HeLa) | Human | MFSD14B | 1:3~1:6 | Negative | Online Inquiry |
KO24754 | MFSD14B Knockout cell line (HCT 116) | Human | MFSD14B | 1:2~1:4 | Negative | Online Inquiry |
KO24755 | MFSD14B Knockout cell line (HEK293) | Human | MFSD14B | 1:3~1:6 | Negative | Online Inquiry |
KO24756 | MFSD14B Knockout cell line (A549) | Human | MFSD14B | 1:3~1:4 | Negative | Online Inquiry |
MFSD14B Gene Knockout Cell Lines represent a cutting-edge resource for researchers exploring the physiological and pathological roles of the MFSD14B gene, known for its involvement in various cellular processes including lipid metabolism and cellular signaling. By utilizing CRISPR/Cas9 technology, these cell lines are created to specifically disrupt the MFSD14B gene, allowing for precise modulation of its expression in various cellular contexts.
The primary function of the MFSD14B knockout is to serve as a powerful tool for studying gene function and genetic interactions. Researchers can utilize these cell lines to assess the effects of MFSD14B loss on cellular behavior, signaling pathways, and metabolic processes, providing valuable insights into disease mechanisms, particularly in frameworks involving metabolic disorders and cancer. The absence of this gene allows for a clearer understanding of its role in biological phenomena, which is crucial for both fundamental biology and applied biomedical research.
These knockout cell lines offer significant advantages over traditional methods, such as the use of overexpression or silencing techniques, as they provide an authentic model with stable gene disruption and less variability. Researchers can achieve high reproducibility, enabling more reliable data generation and interpretation. Furthermore, the MFSD14B knockout cell lines are engineered to be versatile and adaptable across various assays, from drug screening to gene expression analysis, enhancing their applicability in both research and potential therapeutic contexts.
For researchers and clinicians, the MFSD14B Gene Knockout Cell Lines stand out as a vital tool in the advancement of genetic studies and therapeutic innovation. With these cell lines, they can unravel molecular mechanisms underlying diseases, ultimately guiding the development of targeted treatments and interventions. Our company, with a robust background in producing genetically modified cell lines and commitment to quality, offers reliable tools that empower scientific exploration and have the potential to accelerate breakthroughs in biomedical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.